[1] | Chao J, Nepo AG, Butt S, Stellrecht KA, Pearce JM, Lepow LM. The use of intravenous palivizumab for treatment of persistent RSV infection in children with leukemia. Pediatrics 2012 (doi: 10.1542/peds.2008-1536, On-line Early Release). |
[2] | et al. Deep sequencing reveals mixed infection of pandemic H1N1/2009 viruses and the emergence of oseltamivir resistance. J Infect Dis. 2011 Jan15;203(2):168-74. |
[3] | Prestidge CB, Brown ME, et al. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis. Pediatr Pulmonol. 2009 Feb;44(2):148-54. |
[4] | Revell P, Garcia C, et al. Prolonged use of linezolid in children with cystic fibrosis: Effect on MRSA isolates in the respiratory tract. Pediatr Pulmonol. 2008 Supplement 31:338-9. |
[5] | Mayo TW, Siegel JD. Active surveillance cultures and contact precautions for control of multidrug-resistant organisms: Ethical considerations. Clin Infect Dis. 2008 Jul 1;47(1):110-6. |
[6] | Ramilo O, Barton T. Nevirapine-associated DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome in an adolescent with HIV infection. Pediatr Infect Dis J 2007;26:1053–56. |
[7] | Sanchez PJ, Mejias A, at al. Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin. Pediatr Infect Dis J.2007;26(4):364-6. |
[8] | Awa E, Anbar RD. Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report. BMC Pediatrics 2007, 7:11. |
[9] | Hoo J. Difficulty in recognizing multiple sulfatase deficiency in an infant. Pediatrics 2006; 117(3):955-8. |
[10] | Pergolizzi JJ. Transient neonatal jitteriness due to maternal use of sertraline (Zoloft) Journal of Perinatology 2004;24(6):392-4. |